期刊文献+

透析前注射单剂量低分子量肝素对透析器复用效率的评价 被引量:6

Evaluation on efficiency of low molecular weight heparin as a single bolus dose with reused dialyzers
下载PDF
导出
摘要 目的 评价血透前注射单剂量低分子量肝素(LMWH)与持续输注普通肝素 (SH)对复用透析器效率的影响。方法 对 30例慢性透析患者进行随机交叉对照研究 ,观察第 1、4次透析的透析器纤维包裹容量 (FBV)、透析前血球压积 (HCT)及透析 2h尿素氮、肌酐清除率 ;另外 ,利用生色底物法测定透析 0h、2h、4h血浆肝素抗 Fxa水平。结果 同SH组比 ,LMWH组透析器复用次数增加 (P <0 0 5 ) ,第 4次复用透析器FBV及透析 2h尿素氮、肌酐清除率无下降 (P >0 0 5 ) ,SH组则下降 (P <0 0 5 ) ,透析 2h两组血浆肝素活性抗 Fxa水平差异无显著性 (P >0 0 5 ) ,透析 4hLMWH组高于SH组 (P <0 0 5 )。结论 透析前单剂量注射LMWH能有效地保护复用透析器清除率 。 Objective To evaluate the efficiency of low molecular weight heparin(LMWH, fraxiparine) given as a single predialysis bolus injection with reused dialyzers in comparison with standard heparin(SH) administered with a continuous infusion. Methods 30 hemodialysis patients were studied in a radomized crossover fashion. Dialyzers fibrer bundle volumes(FBV), predialysis hemocrit and 2 h clearance of urea, creatinine were observed in the first, the fourth dialysis. The plasma heparin activities(anti Fxa levels) were measured by the chromogenic substrate assay in 0 h, 2 h, 4 h of dialysis. Results Significant increase ( P< 0 05) was seen in the number of dialyzer reuse in LMWH group compared with SH group; there was not significant decrease in dialysis FBV as well as 2 h clearance of urea, creatinine ( P> 0 05); in addition, the plasma heparin activity(anti Fxa levels) were comparable in both groups after 2 h of dialysis, however, they were significantly higher after 4 h in the LMWH than those in the SH group ( P< 0 05). Conclusion LMWH as a single bolus dose can prevent decrease in dialyzer clearance. It is clinically worthy of further popularity.
出处 《安徽医科大学学报》 CAS 2001年第2期121-123,共3页 Acta Universitatis Medicinalis Anhui
关键词 肝素 投药 剂量 低分子量肝素 血液透析 heparin/administration and dosage, low molecular weight heparin hemodialysis
  • 相关文献

参考文献9

  • 1Anderson R, Lui F. Increased heparinization and its effection dialyzer reuse. Dial Transpl, 1995;24(8):464~468
  • 2Schrader J, Stible W, Armstrong VW et al. Comparison of low molecular weight heparin to standard heparin in hemodialysis/ hemofiltration. Kidney Int, 1988;33(4):890~895
  • 3Teitel JM, Rosenberg RD. Protection of factor Xa from neutrlization by the heparin-antithrombin complex. J Clin Invest, 1983;71(10):1383~1386
  • 4Shaldon S, Koch KM. Survival and adequacy in long-term hemodialysis(editorial). Nephron, 1998,59(3):353~358
  • 5Wei SS, Ellis PW,Magnusson MO et al. Effect of heparin modeling on delivered hemodialysis therapy. Am J Kid Dis, 1994;23(3):389~394
  • 6Holmer E, Mattson C, Nilsson S. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragment in rabbits. Thromb Res, 1982;25(4):475~479
  • 7Hirsh J, Levine MN. Low molecular weight heparin. Blood,1992;79(1):1~17
  • 8Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparin. Drugs, 1994;40(7):498~504
  • 9Gran E, Siguenza F, Maduall F et al. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis. Nephron, 1996,62(1):13~18

同被引文献63

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部